493 related articles for article (PubMed ID: 24929038)
1. Solid lipid excipients - matrix agents for sustained drug delivery.
Rosiaux Y; Jannin V; Hughes S; Marchaud D
J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
[TBL] [Abstract][Full Text] [Related]
2. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
3. Approaches for the development of solid and semi-solid lipid-based formulations.
Jannin V; Musakhanian J; Marchaud D
Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
Jaspart S; Piel G; Delattre L; Evrard B
Expert Opin Drug Deliv; 2005 Jan; 2(1):75-87. PubMed ID: 16296736
[TBL] [Abstract][Full Text] [Related]
5. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
Pouton CW; Porter CJ
Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
[TBL] [Abstract][Full Text] [Related]
6. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
Güres S; Siepmann F; Siepmann J; Kleinebudde P
Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
[TBL] [Abstract][Full Text] [Related]
7. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing.
Jannin V; Rodier JD; Musakhanian J
Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211
[TBL] [Abstract][Full Text] [Related]
8. Excipients with specialized functions for effective drug delivery.
Hamman J; Steenekamp J
Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
[TBL] [Abstract][Full Text] [Related]
9. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
Arnold YE; Imanidis G; Kuentz M
Drug Dev Ind Pharm; 2012 Oct; 38(10):1262-9. PubMed ID: 22206451
[TBL] [Abstract][Full Text] [Related]
10. Oral lipid-based formulations.
Hauss DJ
Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
[TBL] [Abstract][Full Text] [Related]
11. Lipid-based formulations for oral administration of poorly water-soluble drugs.
Mu H; Holm R; Müllertz A
Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
[TBL] [Abstract][Full Text] [Related]
12. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
Chadha R; Bhandari S
J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
[TBL] [Abstract][Full Text] [Related]
13. Excipient pharmacokinetics and profiling.
Loftsson T
Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
[TBL] [Abstract][Full Text] [Related]
14. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
16. Fatty acids for controlled release applications: A comparison between prilling and solid lipid extrusion as manufacturing techniques.
Vervaeck A; Monteyne T; Siepmann F; Boone MN; Van Hoorebeke L; De Beer T; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):173-84. PubMed ID: 26428938
[TBL] [Abstract][Full Text] [Related]
17. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
[TBL] [Abstract][Full Text] [Related]
18. Stability of nanosuspensions in drug delivery.
Wang Y; Zheng Y; Zhang L; Wang Q; Zhang D
J Control Release; 2013 Dec; 172(3):1126-41. PubMed ID: 23954372
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
Caraballo I
Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
[TBL] [Abstract][Full Text] [Related]
20. Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population.
Albertini B; Di Sabatino M; Melegari C; Passerini N
Int J Pharm; 2014 Jul; 469(1):67-79. PubMed ID: 24768728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
